COEP
Coeptis Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$10.99
−8.57%Leverage
- Debt / equity
- 0.02x
- Net debt / equity
- -0.23x
- Debt / assets
- 0.02x
- Debt / EBITDA
- -0.03x
- Net debt / EBITDA
- 0.45x
Liquidity & coverage
- Current ratio
- 3.25x
- Quick ratio
- 3.25x
- Cash ratio
- 2.90x
- Interest coverage
- -22.39x
- EBITDA / interest
- -18.87x
- Working capital
- $4.1M
Cash & dividend
- FCF / debt
- -23.29x
- Cash flow / debt
- -23.29x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Mar 1, 2026